Auto-antibodies to receptor tyrosine kinases TrkA, TrkB and TrkC in patients with chronic Chagas' disease

Scandinavian Journal of Immunology

Volumn 67, Issue 6, 2008, Pages 603-609

  Lu, B ^a   Petrola, Z ^b   Luquetti, A O ^c   PereiraPerrin, M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Lab Emílio Ribas   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2KAPPA ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE C; SIALIDASE;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CELL INVASION; CHAGAS DISEASE; CONTROLLED STUDY; CROSS REACTION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NERVE CELL DIFFERENTIATION; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; RECEPTOR BINDING; TRYPANOSOMA CRUZI;

ADULT; AGED; AUTOANTIBODIES; CHAGAS DISEASE; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MIDDLE AGED; RECEPTOR, TRKA; RECEPTOR, TRKB; RECEPTOR, TRKC;

EID: 43549115428     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02102.x     Document Type: Article

References (37)

1. Brener Z. Biology of Trypanosoma cruzi. Annu Rev Microbiol 1973 27 : 347 82.
2. Donovan MJ, Miranda RC, Kraemer R et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995 147 : 309 24.
3. Rosenberg I, Prioli RP, Ortega-Barria E, Pereira ME. Stage-specific phospholipase C-mediated release of Trypanosoma cruzi neuraminidase. Mol Biochem Parasitol 1991 46 : 303 5.
4. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001 24 : 1217 81.
5. Tafuri WL. Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. Am J Trop Med Hyg 1970 19 : 405 17.
6. Vega JA, Garcia-Suarez O, Hannestad J, Perez-Perez M, Germana A. Neurotrophins and the immune system. J Anat 2003 203 : 1 19.
7. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000 14 : 2919 37.
8. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 2003 72 : 609 42.
9. Chuenkova MV, Pereira MA. A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells. Mol Biol Cell 2000 11 : 1487 98.
10. Chuenkova MV, PereiraPerrin M. Chagas' disease parasite promotes neuron survival and differentiation through TrkA nerve growth factor receptor. J Neurochem 2004 91 : 385 94.
11. Chuenkova MV, PereiraPerrin M. A synthetic peptide modeled on PDNF, Chagas' disease parasite neurotrophic factor, promotes survival and differentiation of neuronal cells through TrkA receptor. Biochemistry 2005 44 : 15685 94.
12. Chuenkova MV, PereiraPerrin M. Enhancement of tyrosine hydroxylase expression and activity by Trypanosoma cruzi parasite-derived neurotrophic factor. Brain Res 2006 1099 : 167 75.
13. Jeffery CJ. Moonlighting proteins. Trends Biochem Sci 1999 24 : 8 11.
14. Petsko GA, Ringe D. Protein Structure and Function. London : New Science Press Ltd, 2004 : 156 7.
15. Buschiazzo A, Amaya MF, Cremona ML, Frasch AC, Alzari PM. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol Cell 2002 10 : 757 68.
16. McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, Blundell TL. New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature 1991 354 : 411 4.
17. Leguizamon MS, Campetella O, Russomando G et al. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. J Infect Dis 1994 170 : 1570 4.
18. Pereira-Chioccola VL, Schenkman S, Kloetzel JK. Sera from chronic Chagasic patients and rodents infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its amino-terminal and catalytic domain. Infect Immun 1994 62 : 2973 8.
19. de Melo-Jorge M, PereiraPerrin M. The Chagas' disease parasite Trypanosoma cruzi exploits nerve growth factor receptor TrkA to infect mammalian hosts. Cell Host Microbe 2007 1 : 251 61.
20. Luquetti AOaR A Diagnóstico laboratorial da infecção pelo Trypanosoma cruzi (Diagnosis of Trypoanosoma cruzi infection by serological assays), Chapter 17. Rio de Janeiro, Brazil : Guanabara Koogan, 2000 : 344 78.
21. Saavedra E, Herrera M, Gao W, Uemura H, Pereira MA. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J Exp Med 1999 190 : 1825 36.
22. Jullien J, Guili V, Reichardt LF, Rudkin BB. Molecular kinetics of nerve growth factor receptor trafficking and activation. J Biol Chem 2002 277 : 38700 8.
23. Green SH, Rydel RE, Connolly JL, Greene LA. PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor. J Cell Biol 1986 102 : 830 43.
24. Kabat EA. Structural Concepts in Immunology and Immunochemistry. New York : Holt, Rihehart and Winston, 1976 : 547.
25. Yoo EM, Wims LA, Chan LA, Morrison SL. Human IgG2 can form covalent dimers. J Immunol 2003 170 : 3134 8.
26. Maddison PJ, Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum 1977 20 : 819 24.
27. Robertson SC, Tynan J, Donoghue DJ. RTK mutations and human syndromes: when good receptors turn bad. Trends Genet 2000 16 : 368.
28. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001 7 : 365 8.
29. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease - a double-edged sword. Neuron 2002 35 : 419 32.
30. Mesri EA, Levitus G, Hontebeyrie-Joskowicz M, Dighiero G, Van Regenmortel MH, Levin MJ. Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol 1990 28 : 1219 24.
31. Borda ES, Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Int J Cardiol 1996 54 : 149 56.
32. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006 39 : 41 54.
33. Khoury EL, Ritacco V, Cossio PM et al. Circulating antibodies to peripheral nerve in American trypanosomiasis (Chagas' disease). Clin Exp Immunol 1979 36 : 8 15.
34. Ribeiro dos Santos R, Marquez JO, Von Gal Furtado CC, Ramos de Oliveira JC, Martins AR, Koberle F. Antibodies against neurons in chronic Chagas' disease. Tropenmed Parasitol 1979 30 : 19 23.
35. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001 108 : 1097 104.
36. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002 2 : 85 95.
37. Reichardt LF. Neurotrophin-regulated signaling pathways. Philos Trans R Soc Lond B Biol Sci 2006 361 : 1545 64.